Allen Chi-Shing Yu, Ph.D. is a Chevening Scholar 2017/18. He holds a Ph.D. degree in Biochemistry from the Chinese University of Hong Kong, and a MSc in Computer Science at the University of Oxford. He has 10 years of experience in the field of bioinformatics and BigData analysis. During his research career, Allen published 17 international. scientific research articles and presented in 4 international conferences, including on-stage presentations in the Congress On the Future of Engineering Software (COFES) 2011, USA, and Genome Informatics 2014, U.K. Other research highlights include discovering the novel subtype of Spinocerebellar ataxia (SCA40), identifying the cause of pathogenesis for a family with Spastic paraparesis, leading the Gold medalist team in 2011 International Genetically Engineered Machine (iGEM) competition, and co-developing a number of cancer genomics project.. Apart from academic research, Allen is the co-founder of Codex Genetics Limited and Qualife Hong Kong Limited, which aims to provide personalised medicine service in Asia through the use of latest genomics and IoT technology. With the financial and business support from the HKSAR Innovation and Technology Commission, Hong Kong Science Park, and the Chinese University of Hong Kong, Codex Genetics has curated and transformed recent advances in cancer and neuro-genomics research into clinically actionable insights.
